고객센터
찾아오시는길

HOME > 회원마당 > 보도자료보도자료

Stem cells may give a respite to COVID-19 infected

관리자 | 2020.04.06 10:45 | 조회 65

Stem cells may give a respite to COVID-19 infected

https://th.thgim.com/static/theme/default/base/img/author-deafault.pngMini Tejaswi

MARCH 23, 2020 22:31 IST

UPDATED: MARCH 23, 2020 22:31 IST

SHARE ARTICLE

·          

·          

·          

·          

·          

·          0

·         PRINT

·         A A A

It's tough to approach ICMR with novel such ideas: research outfit Advancells

While stem cell treatment is not a technique to eradicate or fix coronavirus completely, there is proof to help the idea that infected patients, under the treatment, might be more receptive to survive the disease.

That's because, stem cells oppose viral infection due to the presence of specific qualities known as interferon gamma invigorated qualities (ISGs). These are present in stem cells before their separation process happens. Thus, stem cells can be expected to survive even if they are transferred into a patient with confirmed infection of coronavirus, as per Vipul Jain, CEO, Advancells, a research firm focusing on therapeutic applications of regenerative medicine.

Mr Jain said, “Even medical science has determined how influenza virus A/H5N1, with a history of causing intense lung injury, was destroyed by human mesenchymal stromal cells (MSCs) in a mouse. Going back to basics has only expanded the chances of positive outcome.''

Mesenchymal stromal cells (MSCs) are those stem cells which can separate into an assortment of cell types. There are several other properties of MSCs which make them suitable for clinical trials, such as they have ability to reduce inflammation thus regulating the immune system back to healthy and an extraordinary capacity to find the damaged tissues in human body. They can even speed up the recovery of those damaged tissues.

For instance, to achieve desired outcome, specialists have used enormous quantities of MSCs with one patient in Baoshan (Yunnan) who got 3 implantations of 50 million umbilical blood cord derived MSCs, while every Beijing patients got 1 mixture of 1 million cells for every kilogram of weight.

According to Advancells observations, MSCs can be acquired from fat, which implies that everybody can use his/her cells, abolishing any contamination or fatalities. In any case, extending them to the amount required for implantation, takes 2 to 3 weeks which is why it is valuable to cryo-conserve (process of preserving cells prone to damage) an individual reservoir of MSCs, that would permit to get to an early and progressively beneficial treatment.

It may be noted that, some 14 trials have been conducted using stem cells to treat coronavirus patients in China. They recommended stem cells may be the option to fix the extreme organ damage brought about by the virus.

“MSCs can lessen the overproduction of immunity cells caused as a response to the virus and lower down the levels of inflammatory substances. Thus, bringing the weak framework and the whole body back to its ordinary state,'' Mr. Jain said.

What can be securely said at this stage following this spearheading study, as per Advancells, is that MSCs demonstrate extraordinary potential to turn into an important part of eradicating something so huge coronavirus itself.

Commenting on India scenario, he further said, “Sadly, India is slow in terms of awareness, also it is tough to convince ICMR with innovative ideas. China had used it and all patients who have gone for stem cell therapy were recovered. Israel just announced they would start a stem cell pilot for treating coronavirus.”

Why you should pay for quality journalism - Click to know more

 

보도자료
번호 제목 글쓴이 조회 날짜
125 "줄기세포로 코로나19로 손상된 폐 치료가능" 학계 주장에 눈길 관리자 225 2020.04.20
124 줄기세포로 '코로나19' 치료 가능할까... 관리자 192 2020.04.20
123 [포스트 코로나]이희영 대한줄기세포치료학회장, 관리자 177 2020.04.20
122 줄기세포 배양문제 해결? 코로나19 치료 해답 이희영 회장, “의사 자율.. 관리자 185 2020.04.20
121 '줄기세포 치료 활성화' 첨단재생바이오법 입법예고 관리자 185 2020.04.20
120 [현장에서] ‘백신·치료제보다 줄기세포’ 코로나19, 맹장 수술비용으로 .. 관리자 124 2020.04.20
119 줄기세포치료학회 관리자 124 2020.04.20
118 "긴급한 코로나19 환자에 줄기세포 치료 적용해야" 관리자 117 2020.04.20
117 "변이 많은 코로나19, 줄기세포 치료가 대안" 관리자 131 2020.04.20
116 "줄기세포로 손상된 폐 재생…코로나19 치료 효과적" 관리자 123 2020.04.20
115 이희영 회장 “치료제·백신 개발 변수많아… 줄기세포 치료가 우선” Ss 143 2020.04.20
114 [TF사진관] '줄기세포 코로나19 치료 가능하다' Ss 139 2020.04.20
113 줄기세포 주사, 면역력 강화에 도움 줄 수 있어 Ss 217 2020.04.14
112 줄기세포 코로나19 치료제 후보 급부상 Ss 255 2020.04.14
111 지방으로 코로나를? 한인 2세, 줄기세포 치료제 눈길 Ss 208 2020.04.14
110 치료제 없는 코로나19…국내 의료진의 긴급처방은? Ss 96 2020.04.14
109 Transplantation of ACE2- Mesenchymal Ste.. 관리자 71 2020.04.06
108 Mesenchymal stem cells and management of.. 관리자 67 2020.04.06
>> Stem cells may give a respite to COVID-1.. 관리자 66 2020.04.06
106 Stem Cell Therapy for COVID-19 Is Gainin.. 관리자 61 2020.04.06